An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia

por Zimmermannova, O, Doktorova, E, Stuchly, J, Kanderova, V, Kuzilkova, D, Strnad, H, Starkova, J, Alberich-Jorda, M, Falkenburg, J H F, Trka, J, Petrak, J, Zuna, J, Zaliova, M
Publicado 2017